GALT Insider Trading Activity and SEC Form 4 Filings
GALT insider trading summary
Over the past 12 months, insiders at Galectin Therapeutics Inc (GALT) reported 59 sales worth $7.8M by 7 insiders and 4 open-market purchases worth $26K by 2 insiders on SEC Form 4. Net insider selling was $7.8M.
Latest GALT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 14, 2026 | Khurram Jamil | Chief Medical Officer | Sell | $83K (16,250 @ $5.13) |
| Jun 29, 2026 | Khurram Jamil | Chief Medical Officer | Sell | $239K (47,467 @ $5.04) |
| Jun 29, 2026 | Harold H. Shlevin | Insider | Sell | $112K (22,268 @ $5.04) |
| Jun 26, 2026 | Khurram Jamil | Chief Medical Officer | Sell | $13K (2,533 @ $5.00) |
| Jun 26, 2026 | Harold H. Shlevin | Insider | Sell | $39K (7,732 @ $5.00) |
| Jun 26, 2026 | Khurram Jamil | Chief Medical Officer | Sell | $10K (2,037 @ $5.00) |
| May 26, 2026 | Khurram Jamil | Chief Medical Officer | Sell | $2K (568 @ $3.10) |
| Feb 6, 2026 | Kary Eldred | Insider | Buy | $810 (300 @ $2.70) |
| Jan 6, 2026 | Khurram Jamil | Chief Medical Officer | Sell | $78K (21,446 @ $3.65) |
| Jan 6, 2026 | Jack W Callicutt | Chief Financial Officer | Sell | $75K (20,354 @ $3.67) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.